a— ci It 1_,

:

Ls I Ls In J )17: oJ SL&ia0 slc,IJ

Ly—ae, J—.4a.a. 3 J5tcr Lt. I

J

I

: Lit) 6-.•

(Toro

a:101-u)) Let)5 (3,—te &iLAJb cIJLo j

j ci l—..,t9e.-4:1-; I J

!)-: 1.) Cr

Lt i1

c j i J----Lo Ji J di; U so

J17.71 ..21

ia.ej11....) 6--

—

ju.d.C.9

c.S cj

r

_3, ..3_ cYaf,...y.ta; -

ITV-4 (19-11.54c.):; — ,) —1

(1.9, Ley-'/ L ,÷1 —A

1itull ‘1.-'-c

LS -1;2,44 6e-1). •

tj; '...:491.5 Lc, _ ) )

Ato alt:419-14.11 — 1 T

$ I L. I

—11./ — t

C.i'drI —

174-911 — 'I a

j, I -41-.P-4AS 1

Cfibt55.9./j5 trii) )

— 1 A

9

e_ff• L •

do -k?..•

(.5 co1/2.--0 (.5.)5 -3_9 .194°J; -"L'..tt I) Ci1j:9:15 SN J L'afi (576C:Se

J.,-4,4et, J.A9T eL, cfe. I .ala jJ I3.oJ%

%L.-5)c' Li

..ej1-1 1/4zil-i-J • " JI-, 29-eafj -;17! -9 ( ilemostasis ) 05S 0 si -e-1J 1-1MC:

)l&L0L (5:43).„,

j J 6:5 (11-1;.4-bo 4—.5.1 Jice, tra.1 • tit 41 4,3

)11 cata.a. J a. I; sific Cj5O Jy ;o Jn 5)14

— ts 5.5i< -ue-, _9 cfi..:":;./— (}195 LL L5i-L;-. ly (-55

j J L.55 d J.; in 11- cnie, Le 5_6 Si .4 Ls JI.B..r-:1 -11". .

(*)j._LS i _LI de 1-6 ca, isS)t,.. AuS,..

orttles: Ca'Attfrti Lie SP-) 4, -1J5L5 ii-11<.-t° ter: 5 crt”..):

' •Le-fa.):5X,J# spry,- t. 45 f_s:45)11 4--J.4 1; • -1.) Ji—LA

cfi LI, uta cje tre .r.:: 1 (5.0 .

_ (s 1-4't. _LISS _it., "Le 1)311,., ..11; 1.5z,fro jtLaI Ls Lt.:4.11,-,i

X s IX ,VIII ,VII s V 1j)..10 6.9 Cr- .43.9.an

. J tz..5)c, (5514-..•)iet

Viscous Metamorphsis kr& 1-7z:10.9 4 ..J:f

j5-Ata (5).1.) L.1) -11- X 'r.r ór

o r 1.1-45,1 tjt.< oadyms:25:5 ctro I u:35

j j-rta or);

/9-t°5-; J.4-1h; J06 cy

:75 --14); 1-77 I jj 6 -Lc 013 X' ea. jK9 6J1.9TI C-'1."Tfrr."; C.L9 IT!) e* LS j-:5

cap_9 tau -L.'S:A°, Lk° ,s,te 1)4 -J ôJjtoJ J

I --N-15-,0119-rp.); ( jo LI -35SL )

Oe J . cs Les -1.:,5er. cra-1:6 Le.9.4.44 1-7t. 479,t)

(:-.7 —:;5N1 4,51A 6 sa5 JAL: j:L- • t, x5,, it.e, Le.:TJJ aC (.55 Li., j Lth JS

r rd. 1‘):3 1: de-tt9-: JL.,1 c, 433O 1.:49 ; 01_4.

oflate1a

° -L! cii-ANf {Jr.; ci;-4-. I—

L.,..—ko* (.5z531,.., (:; 1 K j e5 O .1.41—La r'S LS ji its

• -ti

I al 13 Le...t.9.) tyk,J1..! c.kra. 5)1.; L....trcc.:5_,

,1.9 1 ,,e t..c; „ I. • J'jC ( In vitro ) altze la.;Ti 01.

5 J 17-Qj Le ( (. Las. t. ..35 L3:95:10 r<

• Jj)

e6 cs ita.), c":""4.4 l:7"S°. 1/4:;•6?"):''

1).1 -5k„ ( 5 1.1.1...9.5 ,;:,11.11... 45 05 1::)5 j . L:- UtIc J 0;5

j11 ..112.:„...• . Jlf 0 )1

(s.;.-9-1-:. eat! 65 c•:--J LAAt-IS F:4-; .9-tr 25” ty:S)te

. .1...51.9z,1

a -35iti tsUs.2)1 .1 J1 ..1 -1...)j—t; jty 04,4 le

J.) c)13 ; . C

vs_to t cr,1..j0 )7.1 -1 0.4-.405 V.Z.9 tt:e5 L15:95

tirS)tts J•Ii.5

.62.-z: I L.a.1, ek t j,t Li.,...Rtfrin.t 4,1 cs5e1L).9)1., cfi l

J 3S49 (.3 Jat 30.1...; J. te • L2 L_ (301'.)1.9

Jta) Ji -1-^•:, 6 ; • -L4 if Jilt' Lsie.1.9s• J-11-ki se•-41-:

2 j 019 -51 j-9t-9 ( in vitro ) r-A. LOT c-J5-("'-: çS)L,...ZiL3ç at i

-31-3-114: b 5 • ▪ (-5-1"U-0i—" 114) ush-r-f ja; ( in vivo) Cr

Ls. IJ:I ftiaaJI.Zj i C-'14e5. JL; W1)1 e l -6.7fu • ewi s.c.j i lac tb. c,L5 k 4

J cp Li 6 (c.5.1)Lit 05)6 y.uLZj,%J jt0.65

a.. tje• . 6. y . Uzi - • I

Indomethacinte s J, u (se tt:J1,12, 05;

Sulfinpyraz on 0.9)1.,4e-4 ( ) t57,P4f"fae) t

Chloroquin cit.:511A Mefenamic acid(51...1.01.:a...4t....

Ls' tl• 6 -W5 ot.15 19 LIZ to " )1.9 111, -1 cr.% Phe nylbutaz on

j$N Lot. • a:9-24...0 Platelet release reaction

(A.D.P.inducedi cs

- 0 uz cA;159. tftt

3.9,,Yri; 0 5 CH.) j 0.9.) 1 JeT: - / ;":9 0.9.;) I OJIJ

jtfrou e_5.94,..c )1,15 1/4:1.,1).; 65 &ails

(Pyi imidin ) oe. Jatud-e5 Jeae..*tl %'1- ;1°9} r5 el:""

epinephrin

A.D.P. cx)34.; J crth; j t i,5Ne 4c9j1t, c, • 5- •

glass bead clumafr 113.51- L1 L7-5; Lt. It::-‘• I 0 J p<

cr2i -1.9 0 J.:.

_1)1 • (n) (5•;Z5zitil-rb..9 I •

VK 774- , VK 744 RA 433 RA 233 Dipyridamol

k .1 Itt csizaa.t) tr.;ti ôJ (3,49.1Ths j_tya L.9)1.1 cie

04, lc LAI tre._...9.1 ( in vivo ) -1-fi a Ls at6_az I_Left1

cw5& ( invitro )

1 05. J-2•, ( i; 5-; 1143) t5)-Ce j CO ej. U.': 9 ) 1 -r

rate clomarib ‘•:- in5-6 C.19) 1:1°.9.X 4 imeJe•-•ae:*. ..AzdatcoSe14 C.>76 t“.9sWIC )

glycerfl quaiacolate Pyridinol carbamate,

(Cyproheptadine) Penicillin Initrofurantion , furocemide

e

c eLtJ1jJ L 5 1 Ji a ..a.:a5c_a:919:... ‘1.55

1

)c-c, czmsti-h` c)- tz" CS. .); C.,:e r Cr • Jb4o

: trItfri LI C.?! Lixtd-D-L

t,12)..tr Cx•Tt-sCi. (rit v.55.f trauLai J.0

—efr; clAic ? I jo •

10k.& ..te. , 5 Le I aesj

c.WUi0 (555.&-o.,et-C 64 oi t, LI lati X.X 51)):

r te._11 (btu., s -'ci4 tic if 1.e. J c.1.1.214: 09 .9 JA.99 (5..1 C 3L. f

:19 (.01.1; cys".:61) Ike Jt6.13.; I Job ci L.) (Si) O J2

(,oLc.aiJ ki r.t 65 u;ai iW

( al 110 c, re i Cjie cyt•It cre lia

tputo tr....11.1714.) cif] J ° ° 65o1) j.c. .1) Le .1.!

u — " cs5 I ;Li C.) 14)-- J3-6 i ttiCi tss1 L33 134 % I x % Cfi i •

ca.% 0-14.-I (51--' -3.29I ( F.D.A ) 15,-t)O

a..3— • Tc-LAJtc,

41 LSjAi JSij 1.:).; ...11÷,t au JI3 z.-ie.

0123 scat,,i} J.9.1 ja nis tio5 74,5 j •1494.4.

sJJ_t c,fM,tc t-,..eq 51 tro Lazi, I ci L.) J

• -1-0

:JY5 15s5c —T

6-b1 tth5 k9 3-4 1.fr° 0 &9 Li 6-! C."! Lei

— (-5 11-11511-5 (5 1-ta?‘ Lefras (5 itzkr ft; 0.4-1') •

,s I.9.) 12 Jell cle

J uv, 11—; j I es (jL3l 1.;

t.::.•maji 0 I.J•45.49

Co—intervention —r

(S I ri C.11°) -5 1 CiCs° (S t: " ..1-su-m• 0116) Ls 1m'

CJ /4/ -1.1.91.)--, CP"--CJ • ..s.t.f.; ..11.1 Jp15 s...AL o$a. 1.„44

0 to) Osit 1).; ti,531.4

L...c J Li 10) £a,. o J

Double—blind Study, £

j.” 0Lt Placebo o_11:9::-.1 05./

A

—, OJy I.e- I -Ur aC „a; I J.; Ls E .tieji

J't LU.9 at (54.9 (ric''Ci (_34 &La las (.5 1-Cre'l kJ

Rand= allocalion

0 toj cid; td,,-;;S. I # Lie _LA F ditii insi, toe...,

uoyaSni tot cis J ty:S

i.iic. (s aapfiike 4; LA a,

tr. yvt. t.5 ditin —1

01--Cr A•7,' }—±Z.; I (:)..) -te (5 1cjJ 6.9A9 le3 Ob. _t•d I) 1 (.5 1.$

0.4.1.10Jajt:-.5A.,J0.1” crag oki,..), 4 jiLel c:_i_a tkorto

o tit leiji 5.1 1 is .11.1 da.e.6 cp..; • „

1 _13_;65 _y

C,2 (fa Is cid-Mg ilea', 4e L., an.JI.c

..9 trAti.) 62:•-•‘"e. Lf• C) 1-,-!-; c;

0,11 —1 ED 1- (.3 Ife (5.)5)0 ez...5a5 Lsi5 7.4,47

d:Lti I J ti

J2 a jlj 4 citeLs— c.,tt

& J altc.9 .t le a o..Lt Ges J. 16.0.1.74 65 4,1:

a

6 jto:1 /44.1 (.51 16) J Lcl 154 15 a As) ti c • cs

-1 •J:1) P6 I5 0546 JO' —9

5!'tt—'t3) 1:":!‘ • pity:A LiA

(51b 1,3)-1 tra4.- -3 13 rit-- c• -3 C.• 1-Atc; (-5 j AP I -c-4.4

OerT J.1.71r 1.:$51,% 1) fra t).5.) ) -Ltitt

Cy!)-te,f A—.9; efe: cfro

:L5s—i •

toz; 0_ A n . .3).0 J LSI

Li.e to c Jr 0.: 46 %z...o . bojJ ce.1 )1

_ t„,.; pua .

dA EN.° ..15,4,4 ci 6:9..K. 1.1; .tyzaw 05A0

cy,1e3 J.; . tyyx.:5 -le l. o

ii.k) e .33-!,, J le rem treST .40-• 5t...) -1 691.9 0 -1.9-)

Ijo f. to.:;_ey trio 3 J4.9_,f,.• L]Jc. lJGLt, (:) 1.;.) I

03 ; tra:, (.5 I"; •3,.. 09.5t7.1 • .J3.4",

: '-j,Ii — T

trj54°T,1 J". ( le rtJ I atIJJ440-. .11-! 6 -Lt. L,51.4( 1,9 Lb Xi- ts., (.5N sfrIc

J J , L-J lo.0 cri-91 Cellar

Je pty.04.0 -to (j)5.; ti.;51o,r; 0540 ILtu) CM

a. cfi t-15 j345 iste 1E, u„1.•,..:: • • 1 .3.40 , 6 .0

-tat lt 4atJ d4q ,)10).)

we 6 J.JOJJ eeAZJnic

"CI 6 -L:7; tfi (5194°T 'S It-1J ( Ne. 63.9; ) to)J y t L.,AL

f;.; c„; . 1.4 cr..; c.ea: c.-tiA

0—.1t5.1%.t . tros-b-so eL,IrJI.Lo 0.1 ol,JD o5: tiolO ea k. 043 J.;

1 1

I I t-5.9.1.11

11-1 L ti• 1;j1 . ..A.Z1 JI

,5 „LA.! •C crown) ,) t ,Lt Ls Lc, -5511)./ ly, o.LatLt

.11 J A J 7.7 0 J .3 Na. II ce 1.1.4t 1)

.

0— —

J y4n1 " • ....I \.16., 65

Ls-) ( High flow

Let:))1 (.5 -11 LL....75:1, (5123 _t ;4:J ne

J. a ( USI, 5.; le (ri-Joi; L ,s421

(.5 12) j

ty--;1.! (lir! 6'SJ Is• t7s-r3 6 j ti li tc'en•J -3

rS . ..,:;-&e.1 • 5:9 I , g 1 6

Ji .1 c) tAt.; r1 o ji

' -'

—174 • 49-AY' 190' 5Oifrc tt 6 1:15 ete.Pk9

6cJA c):5:1>L4 jcs. Jos. L5J1:Ato drcto J 0 toes. .j

I T

dinyridamole • ( Jlfr.c (Jiz; )

?"71--r j CJIJL. £j.1 a 0 1"t"; +.6)1t 6 *-1-4 ets C1.9) 1..el •(..)121-19-4"..9

exio aut..) ))L, _Hrs. eLe crtz,

6 7,e„ri I

_ Jr Lae lee, Ls ,s1 o -art ,,,ieJ.Jt..(rj)i (.35„.. 0 jj5

Coumadin cfic)13)-5 -"it! -3.fi Ir.'', L.-e5s1

‘.1-••1 6J1 J

Lets s

j Jr 47liel: 42.) tC c' 5#t"

— tilciln .7 ci • -if 0—mitt (5;291r L2 tiz;e-0--b3..)

6—j1.19J 040 • • J

Placebo tej 'pir J C15

O., aIJIJ()Lt.) •

I /T4 1-!LjJajIJr. J—i2J -11 crinT ..9-!--)te

. 49.1 c,L OjJ5 Jf -')J7cJr" J.-2.; JP -.9.e

a t 1 i -.1 5 J Jj (5.15.141 J___

.Zi J,)c 049-141.

1 1-

. c3AJ,a$ £Ik9 ..)3.e.; (}L5tJ tr,..itt9

Joe,: Ls r; E L., -In

651.vIstim r

Liscl-ae., '5 CicitUi I 3

• 1.33)

-•:! 1 • •1•2 4! -a-f; jC; trj lilatf-f 65 61:•;35 6.0 Cfr'ar ) cr3j-94°T JA9c

t.ru Lei 4,1€1/21•1 T • j 0-40tetio

Al A 1÷7, , 1)1 Ss--; J L5 -to 's5i JU J.LIZIJ

461111,, (>11 13,„ t.14 • Jj.; nu:J.5 c,A.:, 0.5 , °me %) tyi,„,,,,T

e , • tv-- °Sr' — • 3,c c.) Icti 631;5 -)3÷; cs3 U•;1

t_r3,40);3.): cyck't 7e) •-1 -1-; le.) 3r -,e-4 (.5 ti5t2T5.1 65;) I a -Lt, J1 -1

c_0AaJLJ t • ;

It! Ls); 1.)

rib • '44 6 r t o-f

(-::: C454°T Crfi.16).5 re -) • 65 cL•m4.411

)11.• r •AD) okp b !y Ise jet _II, 1

ve-,49-tcl

:Y- dsfs1tvt'

j:. OSA. <IS ,5 1 alL. )4. j s5

j -1 (5 r 1-u•-• I 65 XI 6 JJ5 .%..)1.)5 C.) %ft j, .1" :4‘.; • '" j'A° cfSelerf

(amaurosis fuga e,

csis' %Ate

6 4:5 c..09-1, FL) I.! .19,1 65 cr; Lott, ci,,,e3:.; ioj I 6 je.

. 6 c.15 "cf. rs

cre,r.;+..) J (3

1.:7 tr A-) C.' Lae Lej Xs 1,3

• C..al .-3-ct 6 ual

15.9)P t.6":* -3-.! C.) Li le:JJ I JOJf5.OS. Ls-L-c• ese t;_n '

_u_ty, 1 .4„., j1 csileT 1 o , 5;1' ...11 j LI tC...t. 1 lt cVAo

cs E..9,..":„ (34,1, „„)-;..,.. J.9., _13 U.' 1 1

j— Ortit:11-! • -)-41-1-•° J--41JJ ‘e.f5 6:5— tit° cr;e-ii:

. pm; .3 .A.,Co )51, .1.01:A9 0; )151; ue,

J __Y_ 4:5,-tut• Loss to5 ciay C.5IAJJitaLs Ifi

-"meh •-: 1:i J&•-(L'a {L.9tre" 61-"Al (55.9)J11 J

1 0

1.1740 di c.:,„ 1 ( tAJI `' • r5jL.a CS' fiL" 1_9n÷a )

t Oat. "2 Lsi to T

X J ,iL e t aJ.Set. 5o 1 azt. I .3 r; Lc 4..tia

rbi.c) cat, „5:5L e 55 re-: • a-4J t Le--77

4 1 ' 1 j t 1 .1 I r.)-15 • a I 'aJ J .se

5ilo JUo J..nOLL11 :5 : C

c.L.—tti ;as , c- tt5 IA '

e tcs .A cits- ca; 0.415..,,,s J.C..)1.52 •

.) +.124' IS Ci `t)

u - r ij *fr.,* (.5 1). 1 c r▪ ho.

r -1 -1-2z; 0 -156e r5 • ..3 Lt

. -3.29T -1.; • .x.:5 c7; 1„. OS (

Vol. 293 No, 23

" PLATELET-INHIBITING DRUGS GENTON'Er AL. 1 177

_Table 1. Randomized Trials in Cerebrovascular Disease.

Smart Moo DAILY CONDITION DESIGN . 'AvrRAnt 'IMAM or Dust --- Foreow-ur

DATA • ' -.' PESIOD

CONTROLS

tont-arrant placebo

'

SAVA%

, - tensed , control

TIA (%)

Prated control

(VA CY)

treated coastal

01 AIII 1'4)

treated conical

Acheson et al" Dipyridamole 400 mg TIA + ' + 14 mo 77 ! 76 . 38 43 . 6 9 10 8 CVA

Dmyridamolc 800 mg TIA + II mo . 62 ' 66 16 25 II 6 8 5 CVA

Acheson & Clofihrate 1-2 g TIA + + Syr• 47 : 48 17 15 49 46 49 42 Hutchinson" CVA

Evans" Sulfinpyrazone .800 mg AF + + 6 wk . 20 i 20 25' 90' — — — — CrOSSOYer ' '

Blakely & Sullinpyrazone 600 mg CVA + + 2-4 yr .• -43 56 30' 56' Dent" .

*DA denotes tranSient ischcmiCallack. CVArcrebrovaseulwarcident.& AFaniumasis tow. 'Mink • olAniatirool ruin

illaNCaretheestimmed4-yeardrathrateslookingaidesihfromvascularcausesonly.

11

\A-e5 ( Clofibrate

a-S-5 )--;a3 ti5s e (.5).A0 t54-e WA- 49,):1-15 1-5 51" 51cti

a—:;:9191.1 J5J yS .31_, c L L5 1,5 &azJU4a c), I

K • lisAP)a..JJz4 (1.d 7,1; 441 a "3-4 .>ju' u3.9, (5)4e.'Oj -5

,2.jtoT lir:z 1 j It Ik.41 e:AL.5)-1- Oft::

JJ o42 0 la) J 041 oeçJ.

fe1e-;1 ( double blind study ) (.5.9-1h (-9:-fr (.0 saj 1114 fr: 41. 0 51

w )t-w);:: ' 1/49 CA9../IXT: ott-44'1 0:4 (39 1-1 14Y-!1. L'irj -1 65 -) I

irt 1-51:c4.2. 0 tar' 'AA! °Lis' 0d1 ecirNfit-:uh

-11.,i; • 1 5'7 r1-° It! ,d, A

to.-1.

I Lc) 143 4.1;2-) ut-ct,L aa 65 .32 ../1J tpt

LssetiL L'Ll 10.19 . .1.4, fS

C.) LJ "'s c-95-;:fie Ji Ly-!)-: L.!

JdJ.te 3÷.., )1, t, 015 -3.; LD ci3j1),..t 1-f

Er

Alls•°i1 CA' je 1-)I-tt) •-) -"t I di .r.95 ‘-:'.);,• sa-a• '-":- .16•49-: ,"•*.i I a;

j---5 3 J11919 ree alkpoty.si 0 j4) 15 n gi Lei); " Le) .L; G

Jj.odi 1.1.:11..1,21 044.• I

c-:•tkii1,-;OjjS• cr•—t •J Lir ur, : ts) criA ti-;

jLsUJJ..b E Lsrez.-• 1-4:94.),35 La;

L. I 1 A 1. ts 00.9...ca..0,..o.9 • jc co..) < f • ..-L1-.AS etre,"

3 :;..tt c)r-r • Ilbay;..91 Lut cs LJ

6:1-41 1:1; (..$46 J I:C11.3 1 6L r T.;5- I ./?9--<:)-4-1 ..?et) abl3 Os,

oj - I ;,..J . I

j.5 4•0 trix-0.-; (.p.4; be Lk" Icydr. 01;

Li -154n -1 -L; Jac) I J-1-6 is- 1 'Si I C.norl : Ls ae..).9

Cni-Ir • -5 -1-; (.5-3-•bitt-: I ft' 6 C.) -55 Ji 1.9.; -3 Ut9 j3-4 t3 j&L 6 -1'1 1-3.)÷°,3

(-5 -1.3+1rf LS..) !AA) j.lte° tjejt j di) U; j -"-"L' .0" c 0-931.1÷4

_ I (id le_e_b 6 crs...o) L5LJ9 L.; Lr;-z;;).f

c".5.55.9.76 045 J I -3 SA,' L id) .7 1.\ttj...^.> (4" le.......9„.aj;

it

Crttr. ri I • SC's. J le-e. !J.',Wsj I Ja: #05 Uri')

.S4 u.; Ljes. caS 0; Lys, -1 015 o 4.2i5

Lz— I 6 Sty •-l'-" 1.9::".id‘ I (.7: C.6,01 -Leoer; ç53 • tii—J:1 J I cit (II

j 0-1".•"°• Cni !PL. t7"1"5 j.9.fr Lit

4.915""Y) P -"J • ji J-; C.)

J.15.) Io I) PIS is; ̀"- -14 (-; 6•; 119.) rfi °ten r • • C.nri

) ..1st crd je4.4.41 J

6;1 co) C.J.flijr.9 C.rd Mtrl r 1 -*eta:: (-5 J : ;la"' L#.9.t

A95 Lt•)1,-- esi -) • -e.) -) I 0:4•91,0 (5.)!

I din):9- !It cnikr L

erdi tki f-4 ° - Ls5 lerz al Jr I -1/4yeAs L.:-.14.6 ççL, Inset)

t'S I) Cr I) al,f1

oiSJflL , J aS La.,41.,.&u:,Jz, IS ..:5e.5 Ls j I u Ja.t o,J L

3.6 ir.e. I sz j.ixo cj JLcc) • 0 oaI

1;-::•ejr L's Ithes:5-15 cktni j.9, I -Lear. (.5 -$ 1:9 1 • I cht•in